Severe Hypertriglyceridemia (High Triglycerides) Medication Study

Now Enrolling Adults Ages 22 and Older

● Now Enrolling

About this research study

Hypertriglyceridemia refers to an elevated level of triglycerides (TG) or lipids in the bloodstream. A severe elevation of triglycerides can increase a person's risk for pancreatitis. Elevations of TG may also lead to an increased risk of atherosclerotic cardiovascular (CV) events even when the LDL-C is well controlled by statin therapy.

Velocity is conducting a clinical research study for an investigational medication for severe hypertriglyceridemia.

Eligible participants...

Must be age 22 and older
Must have fasting TG levels ≥400 mg/dL (bloodwork available at no cost)
Must be on stable lipid modifying therapy (LMT)
Must NOT have Type 1 diabetes
May receive compensation for study-related time
Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

More information about participating in a clinical trial...

After you submit your information, a Velocity enrollment specialist will contact you.

Participating in a study is an important decision — we’re here to help you before, during, and after studies.

Please note: Health insurance is NOT required to join.

Is participation voluntary after I submit my information?

Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the product being studied, the participant’s role in the study, potential side effects, the number of visits that may be required, and more. Participants must sign an informed consent form to join the study.

Will I receive compensation?

While participation in a clinical study is voluntary, you may be paid for study-related time. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible payment with you.

Enter your info

This field is for validation purposes and should be left unchanged.

Name(Required)

Phone(Required)

Date of birth(Required)

Age can help us determine study eligibility (you must be age 18 or older to submit this form).

Month

Day

Year

Location and study of interest(Required)

Gender

Preferred language

Are you Hispanic or Latino?(Required)

Race(Required)

Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.

American Indian or Alaskan Native

Asian

Black or African American

Native Hawaiian or Other Pacific Islander

White or Caucasian

This field is hidden when viewing the form

MobileOptIn

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and you consent to receiving telephone calls and/or emails from Velocity Clinical Research or a third party on behalf of Velocity Clinical Research. For any help regarding messaging, please email us at [email protected]. For full details, refer to Velocity's privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

Study Locations

Syracuse, New York • Velocity Clinical Research

5000 Brittonfield Parkway, Suite B105, East Syracuse, NY 13057
Phone: (315) 760-5905

Los Angeles, California • Velocity Clinical Research

1127 Wilshire Blvd, Suite 805, Los Angeles, CA 90017
Phone: (213) 483-1800

Van Nuys, California • Velocity Clinical Research

15211 Vanowen Street, Suite 100, Van Nuys, CA 91405
Phone: (818) 532-6880

Huntington Park, California • Velocity Clinical Research

6011 Pacific Blvd, Suite 116, Huntington Park, CA 90255
Phone: (323) 588-1968